Julia M Farquhar1, Gregory L Stonerock1, James A Blumenthal2. 1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC. 2. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC. Electronic address: james.blumenthal@duke.edu.
Abstract
BACKGROUND: Anxiety is common in patients with coronary heart disease (CHD) and is associated with an increased risk for adverse outcomes. There has been a relative paucity of studies concerning treatment of anxiety in patients with CHD. OBJECTIVE: We conducted a systematic review to organize and assess research into the treatment of anxiety in patients with CHD. METHODS: We searched CCTR/CENTRAL, MEDLINE, EMBASE, PsycINFO, and CINAHL for randomized clinical trials conducted before October 2016 that measured anxiety before and after an intervention for patients with CHD. RESULTS: A total of 475 articles were subjected to full text review, yielding 112 publications that met inclusion criteria plus an additional 7 studies from reference lists and published reviews, yielding 119 studies. Sample size, country of origin, study quality, and demographics varied widely among studies. Most studies were conducted with nonanxious patients. The Hospital Anxiety and Depression Scale and State-Trait Anxiety Inventory were the most frequently used instruments to assess anxiety. Interventions included pharmacological, counseling, relaxation-based, educational, or "alternative" therapies. Forty (33% of total) studies reported that the interventions reduced anxiety; treatment efficacy varied by study and type of intervention. Elevated anxiety was an inclusion criterion in only 4 studies, with inconsistent results. CONCLUSION: Although there have been a number of randomized clinical trials of patients with CHD that assessed anxiety, in most cases anxiety was a secondary outcome, and only one-third found that symptoms of anxiety were reduced with treatment. Future studies need to target anxious patients and evaluate the effects of treatment on anxiety and relevant clinical endpoints.
BACKGROUND:Anxiety is common in patients with coronary heart disease (CHD) and is associated with an increased risk for adverse outcomes. There has been a relative paucity of studies concerning treatment of anxiety in patients with CHD. OBJECTIVE: We conducted a systematic review to organize and assess research into the treatment of anxiety in patients with CHD. METHODS: We searched CCTR/CENTRAL, MEDLINE, EMBASE, PsycINFO, and CINAHL for randomized clinical trials conducted before October 2016 that measured anxiety before and after an intervention for patients with CHD. RESULTS: A total of 475 articles were subjected to full text review, yielding 112 publications that met inclusion criteria plus an additional 7 studies from reference lists and published reviews, yielding 119 studies. Sample size, country of origin, study quality, and demographics varied widely among studies. Most studies were conducted with nonanxious patients. The Hospital Anxiety and Depression Scale and State-Trait Anxiety Inventory were the most frequently used instruments to assess anxiety. Interventions included pharmacological, counseling, relaxation-based, educational, or "alternative" therapies. Forty (33% of total) studies reported that the interventions reduced anxiety; treatment efficacy varied by study and type of intervention. Elevated anxiety was an inclusion criterion in only 4 studies, with inconsistent results. CONCLUSION: Although there have been a number of randomized clinical trials of patients with CHD that assessed anxiety, in most cases anxiety was a secondary outcome, and only one-third found that symptoms of anxiety were reduced with treatment. Future studies need to target anxiouspatients and evaluate the effects of treatment on anxiety and relevant clinical endpoints.
Authors: Ad Appels; Therese van Elderen; Frits Bär; Gerda van der Pol; Ruud A M Erdman; Maarten Assman; Wim Trijsburg; Rob van Diest; Jan van Dixhoorn; Susanne S Pedersen Journal: J Psychosom Res Date: 2006-07 Impact factor: 3.006
Authors: Kara Zivin Bambauer; Onesky Aupont; Peter H Stone; Steven E Locke; Mariquita G Mullan; Jane Colagiovanni; Thomas J McLaughlin Journal: Psychosom Med Date: 2005 Jul-Aug Impact factor: 4.312
Authors: Rejane K Furuya; Eliana C Arantes; Carina A M Dessotte; Marcia A Ciol; Jeanne M Hoffman; André Schmidt; Rosana A S Dantas; Lidia A Rossi Journal: J Adv Nurs Date: 2014-11-17 Impact factor: 3.187
Authors: François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin Journal: JAMA Date: 2007-01-24 Impact factor: 56.272
Authors: David Hevey; Angela Brown; Alison Cahill; Helen Newton; Mary Kierns; John Henry Horgan Journal: J Cardiopulm Rehabil Date: 2003 Jan-Feb Impact factor: 2.081
Authors: Andrew J Coull; Valerie H Taylor; Rob Elton; Peter S Murdoch; Allister D Hargreaves Journal: Age Ageing Date: 2004-05-10 Impact factor: 10.668